Pediatric autoimmune blistering disorders – a five‐year demographic profile and therapy experience-Reference-Cited by-同舟云学术

Pediatric autoimmune blistering disorders – a five‐year demographic profile and therapy experience

Published:2022-07-27 Issue:12 Volume:61 Page:1511-1518
ISSN:0011-9059
Container-title:International Journal of Dermatology
language:en
Short-container-title:Int J Dermatology

Author:

Mahajan Rahul¹^ORCID,Handa Sanjeev¹,Kumar Sheetanshu¹^ORCID,Chatterji Debajyoti²,Saikia Uma Nahar²,De Dipankar¹

Affiliation:

1. Department of Dermatology, Venereology, and Leprology Postgraduate Institute of Medical Education and Research, Sector 12 Chandigarh India

2. Department of Histopathology Postgraduate Institute of Medical Education and Research, Sector 12 Chandigarh India

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijd.16314

Reference16 articles.

1. Retrospective Study on Autoimmune Blistering Disease in Paediatric Patients

2. Autoimmune bullous disease in childhood

3. Long‐term evolving profile of childhood autoimmune blistering diseases: Retrospective study on 38 children

4. Spectrum of autoimmune bullous diseases among children in Kuwait

5. Spectrum of autoimmune bullous diseases in Northern Greece. A 4‐year retrospective study and review of the literature;Patsatsi A;Acta Dermatovenerol Croat,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rituximab in the treatment of severe childhood pemphigus vulgaris accompanying phenylketonuria: A case report;Indian Journal of Dermatology, Venereology and Leprology;2024-07-19

2. Diagnosis, treatment, and long‐term outcomes of pediatric pemphigus: a retrospective study at tertiary medical centers;International Journal of Dermatology;2024-05-31

3. Vesiculobullous diseases in patients under the age of 18-A Retrospective study in a group of Iranian;journal of research in dental sciences;2023-12-01

4. Severe Pemphigus Vulgaris Resistant to Conventional Therapies and with Hypersensitivity to Rituximab in a 12-Year-Old Child;Children;2023-05-24